Novel Nanocarriers-Based (Bio)Chemical Sensors in Medicine

A special issue of Chemosensors (ISSN 2227-9040). This special issue belongs to the section "(Bio)chemical Sensing".

Deadline for manuscript submissions: 31 July 2024 | Viewed by 1558

Special Issue Editors


E-Mail Website
Guest Editor
Department of Chemical Engineering, Physical Chemistry and Materials Science, University of Huelva, Huelva, Spain
Interests: nanomaterials; carbon nanotubes; surfactants; polymers; micelles; liposomes; nanoparticles; DNA; drug delivery nanocarriers; gene transfection; polymers; Physical Chemistry; Kinetics; Thermodynamics.
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Department of Physical Chemistry, Faculty of Chemistry, University of Seville, Prof. García González nº 1, 41012 Seville, Spain
Interests: nanomaterials; polymers; physical chemistry; Kinetics; thermodynamics; carbon nanotubes; DNA; gene therapy; micelles; liposomes; nanoparticles; dendrimers; surfactants
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Nanocarriers-based (bio)chemical sensors in Medicine have emerged as a promising technology with significant potential for revolutionizing healthcare. These sensors utilize nanoscale materials and structures to detect and analyze specific biochemical and chemical signals in the human body, providing valuable diagnostic and therapeutic information.

The utilization of nanocarriers, such as nanoparticles, liposomes, nanofibers, carbon nanotubes, etc., offers several advantages in (bio)chemical sensor design. These nanoscale structures provide a large surface area, high loading capacity, and excellent biocompatibility, allowing for efficient encapsulation and delivery of biomolecules or drugs. Furthermore, nanocarriers can be functionalised with specific receptors, antibodies or enzymes to selectively bind to target analytes, increasing the sensitivity and selectivity of (bio)chemical sensors, and can be designed to respond to stimuli such as pH, temperature or enzyme activity, allowing the nanosensor to dynamically monitor physiological changes and facilitating the detection of diseases at their earliest stages. Moreover, the nanocarriers-based (bio)chemical sensors can be used to evaluate the efficacy of therapeutic treatments and provide valuable feedback on drug release kinetics and distribution within the body.

This Special Issue on “Novel Nanocarriers-Based (Bio)Chemical sensors in Medicine” will provide a forum for the latest research activities in the fields of biomedicine, pharmacy, and chemistry. Both original research papers and review articles are welcome.

Keywords: nanocarriers, (bio)chemical sensors, sensing technology, medical diagnostic, targeted drug delivery and therapeutic intervention.

This special issue is totally included in the focus of "Chemosensors". The preparation of new nanocarriers-based (bio)chemical sensors with applications in medicine; the use of materials for (bio)chemical sensors; the use of nanosystems in diagnostic testing; etc. are research lines belong to the scope of this journal.

Dr. Manuel López-López
Prof. Dr. Pilar López-Cornejo
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Chemosensors is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

22 pages, 1983 KiB  
Review
Can Nano Yield Big Insights? Oligonucleotide-Based Biosensors in Early Diagnosis of Gastric Cancer
by Alexandra E. Avanu, Alexandra M. Ciubotariu and Gianina Dodi
Chemosensors 2024, 12(3), 44; https://doi.org/10.3390/chemosensors12030044 - 06 Mar 2024
Viewed by 1192
Abstract
Gastric cancer (GC) remains a significant global health challenge, with late-stage diagnosis impacting treatment options and decreased survival rates. To address this, there has been a growing interest in the development of innovative screening and diagnostic methods. Over the past 20 years, nanobiosensors [...] Read more.
Gastric cancer (GC) remains a significant global health challenge, with late-stage diagnosis impacting treatment options and decreased survival rates. To address this, there has been a growing interest in the development of innovative screening and diagnostic methods. Over the past 20 years, nanobiosensors have undergone multiple iterations and unveiled remarkable features that pledge to reshape patient care. Despite the excitement over the plethora of ground-breaking advancements for cancer detection, use-ready samples and streamlined healthcare information monitoring and usage, this technology is still awaiting entry into clinical trials, urging a closer gaze within the medical community. Oligonucleotide-based biosensors, leveraging DNA or RNA’s long-term storage of information, offer great specificity and sensitivity, as described throughout this paper. Consequently, this renders them as an ideal choice for revolutionizing GC diagnosis and facilitating early intervention. The aim of this review is to provide an overview of this cutting-edge, invaluable technology and its limitations across various aspects. Full article
(This article belongs to the Special Issue Novel Nanocarriers-Based (Bio)Chemical Sensors in Medicine)
Show Figures

Figure 1

Back to TopTop